Table 2 Surgical details.
LP (n = 173) | Multivisceral LP (n = 123) | p | |
|---|---|---|---|
Indication for surgery, n (%) | < 0.001 | ||
Pancreatic carcinoma | 42 (24) | 38 (31) | |
Neuroendocrine neoplasm | 35 (20) | 12 (10) | |
Cystic pancreatic lesion | 48 (27) | 4 (3) | |
Malignant tumor (not of pancreatic origin) | 13 (8) | 54 (44) | |
Chronic pancreatitis | 29 (17) | 12 (10) | |
Other indication | 6 (4) | 3 (2) | |
Surgical approach, n (%) | < 0.001 | ||
Open | 137 (79) | 120 (98) | |
Minimal-invasive | 36 (21) | 3 (2) | |
Pancreatic stump closure, n (%) | 0.899 | ||
Suture | 118 (68) | 85 (69) | |
Stapler | 55 (32) | 38 (31) | |
Additional patch plastic, n (%) | 35 (20) | 27 (22) | 0.773 |
Oncological lymphadenectomy performed, n (%) | 84 (49) | 103 (84) | < 0.001 |
Additional vascular surgery, n (%) | 10 (6) | 20 (16) | 0.004 |
Splenectomy, n (%) | 134 (78) | 117 (95) | < 0.001 |
Intraoperative need of blood transfusion, n (%) | 25 (14) | 44 (36) | < 0.001 |
Operative time (min), median (IQR) | 169 (94) | 266 (139) | < 0.001 |
